Alyeska Investment Group
DXCM icon

Alyeska Investment Group’s DexCom DXCM Stock Holding History

Alyeska Investment Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-714,466
Closed -$66.7M – 551
2023
Q3 		$66.7M Sell
714,466
-187,727
-21% -$21.2M 0.45% 67
2023
Q2 		$116M Buy
902,193
+189,849
+27% +$23M 0.86% 20
2023
Q1 		$82.8M Buy
712,344
+48,514
+7% +$5.43M 0.72% 32
2022
Q4 		$75.2M Sell
663,830
-51,087
-7% -$5.61M 0.78% 30
2022
Q3 		$57.6M Buy
+714,917
New +$60.6M 0.67% 40
2020
Q2 		– Sell
-4,156
Closed -$280K – 508
2020
Q1 		$280K Buy
+4,156
New +$259K 0.01% 345
2019
Q4 		– Sell
-201,812
Closed -$7.53M – 426
2019
Q3 		$7.53M Buy
201,812
+1,728
+0.9% +$67.1K 0.11% 185
2019
Q2 		$7.5M Buy
+200,084
New +$6.29M 0.1% 195

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Alyeska Investment Group's DXCM Position: Q4 2023 in Review

Alyeska Investment Group sold out of DexCom (DXCM) in Q4 2023, closing a stake of 714,466 shares — an estimated $66.7M sold.

Alyeska Investment Group first reported a position in DXCM in Q2 2019 and held it in 8 quarters. The position peaked at $116M in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Alyeska Investment Group reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 714,466 DexCom shares in Q4 2023, an estimated $66.7M.
  • Alyeska Investment Group first reported a position in DexCom in Q2 2019 and held it in 8 quarters.
  • Alyeska Investment Group's DexCom position peaked at $116M in Q2 2023.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.